Question 1

What specific benefits could I expect from this combination treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension clinical trial (NCT02842359). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension clinical trial (NCT02842359). Contact the study team or your healthcare provider for specific answers.

Question 3

What potential side effects should I be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension clinical trial (NCT02842359). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension clinical trial (NCT02842359). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension clinical trial (NCT02842359). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel or logistical considerations I should know about?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension clinical trial (NCT02842359). Contact the study team or your healthcare provider for specific answers.

What this study is about